Amplifying Advocacy: Addressing Antimicrobial Resistance and Fungal Infections (CE Session)
Includes a Live Web Event on 04/30/2025 at 9:50 AM (PDT)
Description:
This session is part of the Sepsis Alliance AMR Conference 2025.
Antimicrobial resistance (AMR) and fungal infections pose growing threats to global health, yet they remain underrecognized in policy discussions and funding initiatives. This session explores a strategic campaign designed to elevate awareness, drive robust policy changes, and secure critical resources. Key advocacy strategies, including stakeholder engagement with federal agencies, industry leaders, and global health organizations, as well as the role of media and public education in amplifying the conversation will be discussed. Gain insight into targeted policy recommendations, event-driven advocacy efforts, and the measurable outcomes that leverage collaboration and strategic communication to integrate fungal infections into AMR strategies and strengthen the global response to these pressing health challenges.
Learning Objectives:
At the end of the session, the learner should be able to:
- Analyze the impact of antimicrobial resistance (AMR) and fungal infections on public health, identifying key challenges and gaps in current policies;
- Evaluate strategic advocacy approaches, including stakeholder engagement, communication tactics, and policy recommendations, to enhance AMR and fungal infection awareness and funding;
- Develop an action plan to implement advocacy strategies that drive policy advancements, foster collaboration, and amplify public engagement in addressing AMR and fungal infections.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Rob Purdie
Managing Director
MyCARE
Rob Purdie is a lifelong California resident who was diagnosed with Cocci Meningitis in 2012, the most severe type of Valley Fever. Rob relies on daily antifungals to control his disease and has used his experience to help other patients. He has become a leading fungal disease patient advocate.
In 2023 Rob founded MyCARE, the first patient led, pan fungal nonprofit; with a goal to bring fungal patients together to share knowledge and experiences and advocate for better care and increased research for their diseases. Rob is becoming a sought-after speaker and key opinion leader in the fungal and AMR communities. Rob’s legislative efforts have included work on state and federal legislation and appropriations to support fungal research and awareness. Rob is also a member of the WHO Task Force of AMR Survivors and is part of the workgroup developing a Fungal Priority Pathogen List blueprint to provide guidelines to address the pathogens on the list that was created by the WHO in 2022.